Tenderwize
Zurück zur Suche

Léčivé přípravky s obsahem účinné látky Apadamtasa alfa a cinaxadamtasa alfa

Krajská nemocnice Liberec, a.s.·Liberec, Czech Republic·CZK 23.3M | EUR 961.7k·Deadline Jul 09, 2026 · 15 days left·Open·Supplies
Structured notice only
60/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

60 / 100

Complexity

25 / 100

Risk factors

Eligibility criteria, required documents, and detailed specifications are not provided in the structured data or XML no...

Award based on lowest price may lead to aggressive pricing and potential quality concerns, but this is explicit and acc...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • CZK 23.3M estimated value
  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of medicinal products with active substances Apadamtasa alfa and cinaxadamtasa alfa, 1500 IU per vial.
  • Packaging: 1 vial + 5 ml solvent + Baxject + straw.
Show full summary

Open tender for the supply of medicinal products containing active substances Apadamtasa alfa and cinaxadamtasa alfa (1500 IU) to Krajská nemocnice Liberec, a.s., Czech Republic. Single lot, duration 2 years, estimated value 23,302,000 CZK. Award based on lowest price.

Risks

Eligibility criteria, required documents, and detailed specifications are not provided in the structured data or XML no...

Award based on lowest price may lead to aggressive pricing and potential quality concerns, but this is explicit and acc...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Tender must include a price offer for the total estimated quantity over 2 years.

Administrative

  • Tenders must be submitted electronically via the provided submission URL.
  • Submission language: Czech.

Requirements may be incomplete.

Award Criteria

Lot 1

Základním hodnotícím kritériem pro zadání veřejné zakázky je ekonomická výhodnost nabídky. V rámci ekonomické výhodnosti bude zadavatel dle § 114 odst. 2 zákona hodnotit nabídky podle nejnižší nabídkové ceny v Kč bez DPH. Nabídkovou cenou se pro účely hodnocení nabídek rozumí celková nabídková cena za 2 roky plnění za předpokládané odebrané množství zboží uvedená účastníkem v Cenové nabídce. Hodnocení bude provedeno tak, že zadavatel seřadí nabídky vzestupně podle jejich nabídkové ceny v Kč bez DPH a jako ekonomicky nejvýhodnější bude stanovena nabídka s nejnižší celkovou nabídkovou cenou v Kč bez DPH100%

Buyer

Name

Krajská nemocnice Liberec, a.s.

Location

Liberec, CZE

Buyer profile

Open profile

Identifier

27283933

Lots (1)

LOT-0001

Léčivé přípravky s obsahem účinné látky Apadamtasa alfa a cinaxadamtasa alfa

Continuous supply of medicinal products with active substances Apadamtasa alfa and cinaxadamtasa alfa, strength 1500 IU in injection vial, packaging 1+5ML+BAXJECT+STŘ. Delivery based on partial orders over 2 years.

SuppliesEU fundedElectronic submissionSME suitable

CZK 23.3M

Estimated value

Location

CZ051, Czech Republic

Duration

2 YEAR

Category

Medicinal products

Selection criteria

Price

Deadline

Deadline Jul 09, 2026

Procurement Details

Publication date
08 Jun 2026
Notice type
Contract notice — standard
Languages
Czech

Reference metadata

Notice subtype
16
Notice version
1
Legal basis
32014L0024

Reference IDs

Tender ID
392562-2026
Source notice ID
b7a049c3-a850-435d-aa19-733754cecf0e

Documents (2)

Similar tenders